«We are discussing the merits of this compound, the [SMA]
Project and its assets with a whole panel of external interested parties — foundations as well as companies — to see if we can establish a licensing agreement
where this could be developed further,» says Rajan Ranganathan, head of the NINDS's Office of
Translational Research.
From 2001 - 2010 he was an Assistant Professor of Oncology at Cornell,
where his
research efforts were focused on clinical and
translational projects involving cancer control and pharmacological validation of new agents.
He is a Senior
Research Scientist with the Family Translational Research Group at New York University, where he is involved in a wide variety of basic research and preventive intervention p
Research Scientist with the Family
Translational Research Group at New York University, where he is involved in a wide variety of basic research and preventive intervention p
Research Group at New York University,
where he is involved in a wide variety of basic
research and preventive intervention p
research and preventive intervention
projects.